1. Home
  2. AVA vs RCUS Comparison

AVA vs RCUS Comparison

Compare AVA & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avista Corporation

AVA

Avista Corporation

N/A

Current Price

$39.71

Market Cap

3.3B

Sector

Utilities

ML Signal

N/A

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

N/A

Current Price

$23.41

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVA
RCUS
Founded
1889
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
AVA
RCUS
Price
$39.71
$23.41
Analyst Decision
Hold
Buy
Analyst Count
2
10
Target Price
$38.00
$29.20
AVG Volume (30 Days)
655.0K
1.1M
Earning Date
05-28-2026
05-28-2026
Dividend Yield
4.94%
N/A
EPS Growth
3.93
N/A
EPS
2.38
N/A
Revenue
$1,964,000,000.00
$247,000,000.00
Revenue This Year
$0.20
N/A
Revenue Next Year
$4.12
$57.34
P/E Ratio
$16.70
N/A
Revenue Growth
1.34
N/A
52 Week Low
$35.50
$6.79
52 Week High
$43.50
$26.40

Technical Indicators

Market Signals
Indicator
AVA
RCUS
Relative Strength Index (RSI) 40.81 59.75
Support Level $36.51 $20.35
Resistance Level $41.93 $24.45
Average True Range (ATR) 0.83 1.37
MACD -0.30 0.42
Stochastic Oscillator 17.00 77.99

Price Performance

Historical Comparison
AVA
RCUS

About AVA Avista Corporation

Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: